Although it is well established that HIV is the primary T-cell pathogen in the development of AIDS, the variable attack rate, the high incidence of concurrent infections with other viruses, and evidence that herpes viruses and HIV may act synergistically in vitro, suggest that other viral copathogens may be important in the development of AIDS. Furthermore, AIDS patients have a high incidence of Epstein-Barr virus (EBV)-associated B-cell lymphomas, most frequently of the Burkitt type. It has also been shown that only B-cells infected with EBV can be infected with HIV. All of these findings suggest that interactions between EBV and HIV may be important in the pathogenesis of AIDS and AIDS- related lymphoma. We will prospectively study parameters of EBV infection (viral serology, viral shedding, and EBV-transformed peripheral blood lymphocytes) in a cohort of HIV-positive patients who are well and will correlate any observed changes in these parameters with the development of AIDS. We will undertake a detailed study of AIDS-related lymphoma. In this analysis we will determine clonality by immunoglobulin gene rearrangement analysis. EBV genome copy number, EBV strain subtype, and the expression of candidate EBV transforming genes (EBNA2 and LMP), as well as EBV transcriptional activator genes. EBV-positive cells from various sources will be infected with HIV. These paired HIV+ and HIV- B-cell lines will be used to determine the effect of HIV on B-cell interleukin 2 receptor expression, immunoglobulin production, EBV gene expression, and clonagenicity of infected cells. These cells will also be used to determine the effect of a resident EBV genome on HIV expression.

Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1987
Total Cost
Indirect Cost
Name
State University New York Stony Brook
Department
Type
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Morrison, S A; Pearson, S L; Steigbigel, R T (1998) Anti-F(ab')2 antibody in HIV type 1 infection: relationship to hypergammaglobulinemia and to antibody specific to the V3 loop region of glycoprotein 120. AIDS Res Hum Retroviruses 14:491-8
Schubach, W H; Horvath, G; LeVea, C et al. (1997) Chromatin structure of the lymphocyte Fc epsilon receptor gene (CD23): identification of an upstream transcriptional enhancer. J Immunol 158:2228-35
Moorjani, H; Craddock, B P; Morrison, S A et al. (1996) Impairment of phagosome-lysosome fusion in HIV-1-infected macrophages. J Acquir Immune Defic Syndr Hum Retrovirol 13:18-22
Cohen, A J; Steigbigel, R T (1996) Eosinophilia in patients infected with human immunodeficiency virus. J Infect Dis 174:615-8
Handley, M A; Steigbigel, R T; Morrison, S A (1996) A role for urokinase-type plasminogen activator in human immunodeficiency virus type 1 infection of macrophages. J Virol 70:4451-6
O'Riordan, T G; Smaldone, G C (1994) Regional deposition and regional ventilation during inhalation of pentamidine. Chest 105:396-401
O'Riordan, T G; Palmer, L B; Smaldone, G C (1994) Aerosol deposition in mechanically ventilated patients. Optimizing nebulizer delivery. Am J Respir Crit Care Med 149:214-9
O'Riordan, T G; Baughman, R P; Dohn, M N et al. (1994) Lobar pentamidine levels and Pneumocystis carinii pneumonia following aerosolized pentamidine. Chest 105:53-6
Nuovo, G J; Becker, J; Burk, M W et al. (1994) In situ detection of PCR-amplified HIV-1 nucleic acids in lymph nodes and peripheral blood in patients with asymptomatic HIV-1 infection and advanced-stage AIDS. J Acquir Immune Defic Syndr 7:916-23
Suzuki, K; Craddock, B P; Okamoto, N et al. (1993) Detection of human immunodeficiency virus (HIV) by colorimetric assay for reverse transcriptase activity on magnetic beads. Biotechnol Appl Biochem 18 ( Pt 1):37-44

Showing the most recent 10 out of 27 publications